Valpin 50 en es it fr

Valpin 50 Brand names, Valpin 50 Analogs

Valpin 50 Brand Names Mixture

  • No information avaliable

Valpin 50 Chemical_Formula


Valpin 50 RX_link

No information avaliable

Valpin 50 fda sheet

Valpin 50 msds (material safety sheet)

Valpin 50 Synthesis Reference

No information avaliable

Valpin 50 Molecular Weight

362.346 g/mol

Valpin 50 Melting Point

329 oC

Valpin 50 H2O Solubility

1600 mg/L

Valpin 50 State


Valpin 50 LogP


Valpin 50 Dosage Forms

Tablet (oral, 50mg)

Valpin 50 Indication

For use in conjunction with antacids or histamine H2-receptor antagonists in the treatment of peptic ulcer, to reduce further gastric acid secretion and delay gastric emptying.

Valpin 50 Pharmacology

Anisotropine methylbromide is a quaternary ammonium compound. Its use as treatment adjunct in peptic ulcer has been replaced by the use of more effective agents. Depending on the dose, anisotropine methylbromide may reduce the motility and secretory activity of the gastrointestinal system, and the tone of the ureter and urinary bladder and may have a slight relaxant action on the bile ducts and gallbladder. In general, smaller doses of anisotropine methylbromide inhibit salivary and bronchial secretions, sweating, and accommodation; cause dilatation of the pupil; and increase the heart rate. Larger doses are required to decrease motility of the gastrointestinal and urinary tracts and to inhibit gastric acid secretion.

Valpin 50 Absorption

Gastrointestinal absorption is poor and irregular. Total absorption after an oral dose is about 10 to 25%.

Valpin 50 side effects and Toxicity

No information avaliable

Valpin 50 Patient Information

Valpin 50 Organisms Affected

Humans and other mammals